TG Therapeutics stock slid nearly 7% Friday — what to watch next week for TGTX
TG Therapeutics shares fell 6.6% to $28.47 on Friday, trading 3.3 million shares. CEO Michael S. Weiss received 622,000 restricted shares in a performance award, a filing showed. The company is set to present at the J.P. Morgan Healthcare Conference on Tuesday. Traders await updates on Briumvi’s demand and insurance coverage.